52 related articles for article (PubMed ID: 38737683)
1. Comprehensive pan-cancer analysis: essential role of ABCB family genes in cancer.
Xiao HN; Zhao ZY; Li JP; Li AY
Transl Cancer Res; 2024 Apr; 13(4):1642-1664. PubMed ID: 38737683
[TBL] [Abstract][Full Text] [Related]
2. Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment.
Tian H; Cao J; Li B; Nice EC; Mao H; Zhang Y; Huang C
Bone Res; 2023 Feb; 11(1):11. PubMed ID: 36849442
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment.
Wu B; Shi X; Jiang M; Liu H
Mol Cancer; 2023 Feb; 22(1):38. PubMed ID: 36810098
[TBL] [Abstract][Full Text] [Related]
4. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
5. Evolutionary history of ATP-binding cassette proteins.
Srikant S
FEBS Lett; 2020 Dec; 594(23):3882-3897. PubMed ID: 33145769
[TBL] [Abstract][Full Text] [Related]
6. Review article: liver disease in adults with variants in the cholestasis-related genes ABCB11, ABCB4 and ATP8B1.
Nayagam JS; Williamson C; Joshi D; Thompson RJ
Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1628-1639. PubMed ID: 33070363
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug Resistance.
Luo X; Teng QX; Dong JY; Yang DH; Wang M; Dessie W; Qin JJ; Lei ZN; Wang JQ; Qin Z; Chen ZS
Front Pharmacol; 2020; 11():1208. PubMed ID: 32903706
[TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of the ABC transporter family in hepatocellular carcinoma reveals the importance of ABCB6 in regulating ferroptosis.
Zhang J; Zhang X; Li J; Song Z
Life Sci; 2020 Sep; 257():118131. PubMed ID: 32710948
[TBL] [Abstract][Full Text] [Related]
9. Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells.
Feng W; Zhang M; Wu ZX; Wang JQ; Dong XD; Yang Y; Teng QX; Chen XY; Cui Q; Yang DH
Front Oncol; 2020; 10():955. PubMed ID: 32670878
[TBL] [Abstract][Full Text] [Related]
10. EGFR Blockade Reverses Cisplatin Resistance in Human Epithelial Ovarian Cancer Cells.
Poursheikhani A; Yousefi H; Tavakoli-Bazzaz J; Seyed H G
Iran Biomed J; 2020 Nov; 24(6):370-8. PubMed ID: 32660222
[TBL] [Abstract][Full Text] [Related]
11. Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.
Bader JE; Voss K; Rathmell JC
Mol Cell; 2020 Jun; 78(6):1019-1033. PubMed ID: 32559423
[TBL] [Abstract][Full Text] [Related]
12. Profiling global cancer incidence and mortality by socioeconomic development.
Lortet-Tieulent J; Georges D; Bray F; Vaccarella S
Int J Cancer; 2020 Dec; 147(11):3029-3036. PubMed ID: 32449164
[TBL] [Abstract][Full Text] [Related]
13. Influence of ABCB-1, ERCC-1 and ERCC-2 gene polymorphisms on response to capecitabine and oxaliplatin (CAPOX) treatment in colorectal cancer (CRC) patients of South India.
Varma A; Mathaiyan J; Shewade D; Dubashi B; Sunitha K
J Clin Pharm Ther; 2020 Aug; 45(4):617-627. PubMed ID: 32399998
[TBL] [Abstract][Full Text] [Related]
14. Afatinib is active in osteosarcoma in osteosarcoma cell lines.
Cruz-Ramos M; Zamudio-Cuevas Y; Medina-Luna D; Martínez-Flores K; Martínez-Nava G; Fernández-Torres J; López-Reyes A; Solca F
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1693-1700. PubMed ID: 32333142
[TBL] [Abstract][Full Text] [Related]
15. Review of precision cancer medicine: Evolution of the treatment paradigm.
Tsimberidou AM; Fountzilas E; Nikanjam M; Kurzrock R
Cancer Treat Rev; 2020 Jun; 86():102019. PubMed ID: 32251926
[TBL] [Abstract][Full Text] [Related]
16. Hedgehog signalling mediates drug resistance through targeting TAP1 in hepatocellular carcinoma.
Zhou XT; Ding J; Li HY; Zuo JL; Ge SY; Jia HL; Wu J
J Cell Mol Med; 2020 Apr; 24(7):4298-4311. PubMed ID: 32108992
[TBL] [Abstract][Full Text] [Related]
17. Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer.
Zhou HH; Chen X; Cai LY; Nan XW; Chen JH; Chen XX; Yang Y; Xing ZH; Wei MN; Li Y; Wang ST; Liu K; Shi Z; Yan XJ
Front Oncol; 2019; 9():1398. PubMed ID: 31921655
[TBL] [Abstract][Full Text] [Related]
18. ABC Family Transporters.
Liu X
Adv Exp Med Biol; 2019; 1141():13-100. PubMed ID: 31571164
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
